characterized peanut allergen oral immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for characterized peanut allergen oral immunotherapy, covering 2021-11-02 to 2021-11-02. Get the full timeline:
Most recent: Clinical Trial Update: Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT [Phase 2]